Cointime

Gilead Sciences

company

About

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

  • 10001 - max

Highlights

Investments
3
Lead Investments
3
Acquisition
1

Details

Industries
Biopharma,Biotechnology,Health Care,Manufacturing,Pharmaceutical
Founded date
Jun 22, 1987
Number Of Employee
10001 - max
Operating Status
Active

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases.

Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Investments

Number of Investments
Number of Lead Investments
3
3
Gilead Sciences has made 3 investments. Their most recent investment was on Feb 1, 2021, when Arcus Biosciences raised $220.35M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 1, 2021 Arcus Biosciences
Post-IPO Equity $220.35M Biotechnology Yes
May 28, 2020 Arcus Biosciences
Post-IPO Equity $200M Biotechnology Yes
Jul 14, 2019 Galapagos
Post-IPO Equity $5.10B Biopharma Yes

Acquisition

Gilead Sciences has acquired 1 organizations. Their most recent acquisition was Kite Pharma on Aug 28, 2017. They acquired Kite Pharma for $11.90B.

Date Company Name
Industry Acquisition Type Price
Aug 28, 2017 Kite Pharma
Biotechnology acquisition $ 11.90B Detail
Cointime
เนื้อหา
บริษัท